» Authors » Piotr Grabarczyk

Piotr Grabarczyk

Explore the profile of Piotr Grabarczyk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 563
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Susemihl A, Geist N, Grabarczyk P, Schmidt C, Delcea M, Schulig L
Proteins . 2025 Feb; PMID: 39976228
The transcription factor B Cell Lymphoma/Leukemia 11B (BCL11B) exerts a bi-directional function in cancer, with its role as an emerging therapeutic target in cancer treatment being particularly intriguing. BCL11B knockouts...
2.
Kopacz A, Kubicka-Russel D, Liszewski G, Sulkowska E, Chrzanowska A, Zwolinska P, et al.
Viruses . 2025 Jan; 17(1). PMID: 39861849
In the 1980s, Poland was a medium-endemic country, with one of the highest incidences of hepatitis B in Europe (45/10 inhabitants). Pursuant to the WHO guidelines, obligatory vaccination was introduced...
3.
Faddy H, Osiowy C, Custer B, Busch M, Stramer S, Dean M, et al.
Vox Sang . 2024 Mar; 119(7):745-751. PMID: 38516962
Background And Objectives: Nucleic acid-amplification testing (NAT) is used for screening blood donations/donors for blood-borne viruses. We reviewed global viral NAT characteristics and NAT-yield confirmatory testing used by blood operators....
4.
Faddy H, Osiowy C, Custer B, Busch M, Stramer S, Adesina O, et al.
Vox Sang . 2024 Feb; 119(4):315-325. PMID: 38390819
Background And Objectives: Nucleic acid amplification testing (NAT), in blood services context, is used for the detection of viral and parasite nucleic acids to reduce transfusion-transmitted infections. This project reviewed...
5.
Kopacz A, Kubicka-Russel D, Liszewski G, Bukowska A, Samek S, Malka D, et al.
Pract Lab Med . 2024 Feb; 39:e00364. PMID: 38328514
In Poland, independent evaluations under the auspices of the Institute of Hematology and Transfusion Medicine (IHTM) are mandated for any new device, assay, systems for screening samples from whole blood...
6.
Radkowski M, Grabarczyk P, Kryczka T, Caraballo Cortes K, Kubicka-Russel D, Janiak M, et al.
Sci Rep . 2023 Nov; 13(1):20045. PMID: 37973814
Most Hepatitis C virus (HCV)-infected subjects develop chronic infection, whereas a minority clear the virus in the early phase of infection. We analyzed factors associated with outcome (chronicity vs clearance)...
7.
Troschke-Meurer S, Zumpe M, Meissner L, Siebert N, Grabarczyk P, Forkel H, et al.
Cancers (Basel) . 2023 Feb; 15(3). PMID: 36765861
Anti-disialoganglioside GD2 antibody ch14.18/CHO (dinutuximab beta, DB) improved the outcome of patients with high-risk neuroblastoma (HR-NB) in the maintenance phase. We investigated chemotherapeutic compounds used in newly diagnosed patients in...
8.
Sulkowska E, Zyskowska A, Grabarczyk P, Letowska M, Parczewski M
Transfusion . 2023 Feb; 63(2):435-436. PMID: 36733256
No abstract available.
9.
Sulkowska E, Masny A, Kalinska A, Kopacz A, Kubicka-Russel D, Marek M, et al.
Transfusion . 2022 Dec; 63(2):349-359. PMID: 36537152
Background: In Poland, hepatitis A virus (HAV) RNA screening was performed in plasma for fractionation usually immediately before shipment. Objective: Our goal was to study epidemiology, rate of transfusion transmitted...
10.
Forkel H, Grabarczyk P, Depke M, Troschke-Meurer S, Simm S, Hammer E, et al.
Oncoimmunology . 2022 Dec; 11(1):2148850. PMID: 36507091
BCL11B, an essential transcription factor for thymopoiesis, regulates also vital processes in post-thymic lymphocytes. Increased expression of BCL11B was recently correlated with the maturation of NK cells, whereas reduced BCL11B...